Meeting
2018 ASCO Annual Meeting
Genetic variants within the glucocorticoids related genes to predict outcome in patients with metastatic colorectal cancer (mCRC).
Authors
Alberto Puccini
Division of Medical Oncology, USC Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA
Alberto Puccini , Fotios Loupakis , Shu Cao , Ryuma Tokunaga , Madiha Naseem , Francesca Battaglin , Martin D. Berger , Michelle McSkane , Shivani Soni , Wu Zhang , Joshua Millstein , Christoph Mancao , Chiara Cremolini , Alfredo Falcone , Heinz-Josef Lenz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Tumor-Based Biomarkers
Citation
J Clin Oncol 36, 2018 (suppl; abstr 12098)
DOI
10.1200/JCO.2018.36.15_suppl.12098
Abstract #
12098
Poster Bd #
211
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Single nucleotide polymorphisms (SNPs) in MHC class I and II genes to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3, MAVERICC, and TRIBE trials.
First Author: Pooja Mittal
Poster
2021 Gastrointestinal Cancers Symposium
Genetic variants involved in the lipid metabolism pathway to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3 and MAVERICC trials.
First Author: Jingyuan Wang
Poster
2013 ASCO Annual Meeting
Use of genetic variants in wnt signaling pathway to predict gender and tumor location dependent survival in metastatic colorectal cancer (mCRC) patients (pts) treated with first-line FOLFIRI and bevacizumab (BEV).
First Author: Yan Ning
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Myostatin/activin pathway gene expression and single nucleotide polymorphisms (SNPs) in metastatic colorectal cancer (mCRC).
First Author: Karam Ashouri